Relyea Zuckerberg Hanson LLC Bristol Myers Squibb CO Transaction History
Relyea Zuckerberg Hanson LLC
- $741 Million
- Q4 2024
A detailed history of Relyea Zuckerberg Hanson LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Relyea Zuckerberg Hanson LLC holds 5,697 shares of BMY stock, worth $341,250. This represents 0.04% of its overall portfolio holdings.
Number of Shares
5,697
Previous 4,596
23.96%
Holding current value
$341,250
Previous $237,000
35.86%
% of portfolio
0.04%
Previous 0.04%
Shares
20 transactions
Others Institutions Holding BMY
# of Institutions
2,763Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$11.4 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.5 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.75 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.7 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.61 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $127B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...